P15——a new tumor suppressor gene

In addition to the tumor suppressor genes such as Rb and p53, it has been found that some molecules of the same class named CKI (cyclin-dependent kinase inhibitor) also play an important role in the inhibition of tumorigenesis and the tumor progression. In the KIP and INK4 families of CKIs, p15 shares extensive homology with p16. Findings in many tumors and their cell lines show that the inactivation of p15 (deletion, mutation, rearrangement, etc.) is very frequent, and inactive p15 is involved in the progress of some tumors. These studies provide evidence that the p15 is a new tumor suppressor gene. Furthermore, the research on the molecular mechanism of p15 in regulation of cell proliferation shows that p15 can inhibit the growth of some kinds of tumor cells, and p15 is the mediator of TGF-β-induced cell arrest. Investigations on p15 in cell differentiation suggest that increased p15 is related to the change of malignant phenotype. These results supply clues for further interpretation about the molecular mechnism of cell cycle control and cell tumorigenesis. And they may provide theoretical and experimental basis for application of p15 to clinical therapy of tumors.     

中国国家开发银行贷款项目资金管理信息系统的设计与实现

以软件工程的观点介绍了一个实用信息管理系统的设计过程，给出了需求分析中的数据流程图、数据字典实例，以及系统功能树、实现平台、技术难点、解决方法和运行效率，最后给出了系统的使用评价．     

原始组织对滚珠轴承钢激光相变硬化的影响

本文通过实验研究了分析了调质和球化退火两种不同原始组织的滚珠轴承钢，经激光相变硬化后，其表层硬度，硬化层深度及显微组织的差异，提出了按使用要求选定原始组织的工艺依据。     

固体酸HY沸石催化合成环十五内酯

以15-羟基十五烷酸甲酯为原料,采用固体酸HY沸石催化剂合成环十五内酯,探讨HY沸石性质与环化反应关系,寻找固体酸催化合成环十五内酯优化条件.实验结果表明,HY沸石颗粒越小,越有利于环化反应;N aY沸石,再经阳离子交换再脱铝催化生成环十五内酯的转化率为:9.02%.     

GCr15钢M/B复合组织中残余奥氏体的作用

研究了残余奥氏体对ＧＣｒ１５ 钢Ｍ／Ｂ复合组织性能的影响。结果表明，残余奥氏体呈条状分布，对Ｍ／Ｂ复合组织的强韧性起着改善作用。     

贝氏体等温淬火工艺在GCr15钢制柱塞套上的应用

介绍了油泵柱塞套淬火工艺的发展,并对GCr15制柱塞套采用马氏体等温分级淬火与贝氏体等温淬火工艺进行了比较,根据GCr15柱塞套的技术要求,给出了贝氏体等温淬火工艺执行过程中的要素控制方法,为柱塞套的热处理生产提供了控制依据。     

原位水热合成La_(1-x)Ce_xCoO_3/SBA-15钙钛矿型催化剂和CO催化氧化反应性能的研究

采用原位水热合成法合成了La1-x Ce x CoO3/SBA-15(x=0.05,0.1,0.15,0.2,0.25,摩尔分数,下同)催化剂,并采用X射线粉末衍射(XRD)、透射电子显微镜(TEM)、N2物理吸附-脱附表征仪(BET)和程序升温还原(H2-TPR)等表征手段对催化剂的结构进行了研究.结果表明:Ce掺杂对催化剂的结构和CO催化氧化性能有较大的影响.在Ce掺杂部分取代La之后,催化剂形成了La1-x Ce x CoO3钙钛矿相,CeO2和Co3O4物相;当Ce的掺杂量为x=0.2时,催化剂的CO催化氧化活性最高.     

Friedrich Miescher Prize awardee lecture review. A conserved family of nuclear export receptors mediates the exit of messenger RNA to the cytoplasm

The distinguishing feature of eukaryotic cells is the segregation of RNA biogenesis and DNA replication in the nucleus, separate from the cytoplasmic machinery for protein synthesis. As a consequence, messenger RNAs (mRNAs) and all cytoplasmic RNAs from nuclear origin need to be transported from their site of synthesis in the nucleus to their final cytoplasmic destination. Nuclear export occurs through nuclear pore complexes (NPCs) and is mediated by saturable transport receptors, which shuttle between the nucleus and cytoplasm. The past years have seen great progress in the characterization of the mRNA export pathway and the identification of proteins involved in this process. A novel family of nuclear export receptors (the NXF family), distinct from the well-characterized family of importin β-like proteins, has been implicated in the export of mRNA to the cytoplasm. Received 23 January 2001; received after revision 12 April 2001; accepted 12 April 2001     

Structural analysis of leucine-rich-repeat variants in proteins associated with human diseases

A number of human diseases have been shown to be associated with mutation in the genes encoding leucine-rich-repeat (LRR)-containing proteins. They include 16 different LRR proteins. Mutations of these proteins are associated with 19 human diseases. The mutations occur frequently within the LRR domains as well as their neighboring domains, including cysteine clusters. Here, based on the sequence analysis of the LRR domains and the known structure of LRR proteins, we describe some features of different sequence variants and discuss their adverse effects. The mutations in the cysteine clusters, which preclude the formation of sulfide bridges or lead to a wrong paring of cysteines in extracellular proteins or extracellular domains, occur with high frequency. In contrast, missense mutations at some specific positions in LRRs are very rare or are not observed at all. Received 4 May 2005; received after revision 18 August 2005; accepted 1 September 2005